annual cash & cash equivalents:
$281.97M-$153.93M(-35.31%)Summary
- As of today (July 4, 2025), BEAM annual cash & cash equivalents is $281.97 million, with the most recent change of -$153.93 million (-35.31%) on December 31, 2024.
- During the last 3 years, BEAM annual cash & cash equivalents has fallen by -$278.03 million (-49.65%).
- BEAM annual cash & cash equivalents is now -49.65% below its all-time high of $559.99 million, reached on December 31, 2021.
Performance
BEAM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$527.91M+$245.94M(+87.22%)Summary
- As of today (July 4, 2025), BEAM quarterly cash & cash equivalents is $527.91 million, with the most recent change of +$245.94 million (+87.22%) on March 31, 2025.
- Over the past year, BEAM quarterly cash & cash equivalents has increased by +$240.06 million (+83.40%).
- BEAM quarterly cash & cash equivalents is now -13.74% below its all-time high of $612.02 million, reached on September 30, 2021.
Performance
BEAM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BEAM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | +83.4% |
| 3 y3 years | -49.6% | +77.8% |
| 5 y5 years | +657.5% | +318.8% |
BEAM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.6% | +21.1% | at high | +237.3% |
| 5 y | 5-year | -49.6% | +657.5% | -13.7% | +442.9% |
| alltime | all time | -49.6% | >+9999.0% | -13.7% | +1318.3% |
BEAM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $527.91M(+87.2%) |
| Dec 2024 | $281.97M(-35.3%) | $281.97M(+22.5%) |
| Sep 2024 | - | $230.20M(-21.4%) |
| Jun 2024 | - | $292.76M(+1.7%) |
| Mar 2024 | - | $287.85M(-34.0%) |
| Dec 2023 | $435.89M(+87.3%) | $435.89M(+157.9%) |
| Sep 2023 | - | $169.05M(-25.0%) |
| Jun 2023 | - | $225.54M(-9.7%) |
| Mar 2023 | - | $249.77M(+7.3%) |
| Dec 2022 | $232.77M(-58.4%) | $232.77M(+48.7%) |
| Sep 2022 | - | $156.51M(-41.1%) |
| Jun 2022 | - | $265.62M(-10.5%) |
| Mar 2022 | - | $296.82M(-47.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $559.99M(+245.3%) | $559.99M(-8.5%) |
| Sep 2021 | - | $612.02M(+188.7%) |
| Jun 2021 | - | $212.01M(+118.0%) |
| Mar 2021 | - | $97.24M(-40.0%) |
| Dec 2020 | $162.17M(+335.7%) | $162.17M(+17.6%) |
| Sep 2020 | - | $137.90M(+10.1%) |
| Jun 2020 | - | $125.30M(-0.6%) |
| Mar 2020 | - | $126.05M(+238.7%) |
| Dec 2019 | $37.22M(-74.6%) | $37.22M(-1.4%) |
| Sep 2019 | - | $37.76M(-0.2%) |
| Jun 2019 | - | $37.85M(-74.2%) |
| Dec 2018 | $146.44M(+7603.5%) | $146.44M |
| Dec 2017 | $1.90M | - |
FAQ
- What is Beam Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Beam Therapeutics?
- What is Beam Therapeutics annual cash & cash equivalents year-on-year change?
- What is Beam Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Beam Therapeutics?
- What is Beam Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Beam Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BEAM is $281.97M
What is the all time high annual cash & cash equivalents for Beam Therapeutics?
Beam Therapeutics all-time high annual cash & cash equivalents is $559.99M
What is Beam Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BEAM annual cash & cash equivalents has changed by -$153.93M (-35.31%)
What is Beam Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BEAM is $527.91M
What is the all time high quarterly cash & cash equivalents for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash & cash equivalents is $612.02M
What is Beam Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, BEAM quarterly cash & cash equivalents has changed by +$240.06M (+83.40%)